Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system
Abstract Embryonic stem cell (ESC)-derived epitopes can act as therapeutic tumor vaccines against different types of tumors Jin (Adv Healthc Mater 2023). However, these epitopes have poor immunogenicity and stimulate insufficient CD8+ T cell responses, which motivated us to develop a new method to d...
Main Authors: | Meiling Jin, Da Huo, Jingjing Sun, Jingchu Hu, Shuzhen Liu, Mingshuo Zhan, Bao-zhong Zhang, Jian-Dong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-02273-8 |
Similar Items
-
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
by: Alberto Grandi, et al.
Published: (2023-09-01) -
OMV Vaccines and the Role of TLR Agonists in Immune Response
by: Francesca Mancini, et al.
Published: (2020-06-01) -
Impact of meningococcal group B OMV vaccines, beyond their brief
by: Helen Petousis-Harris
Published: (2018-05-01) -
Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses
by: Dung T. Huynh, et al.
Published: (2024-12-01) -
Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines
by: Helen Petousis-Harris, et al.
Published: (2019-04-01)